275 filings
Page 2 of 14
8-K
sxm68rkws213lygo490
3 May 23
Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results
4:05pm
8-K
bbmf2q vr
17 Mar 23
Vanda Pharmaceuticals Appoints Dr. Tage Honoré to its Board of Directors
7:05am
8-K
ql0ulk
13 Mar 23
Regulation FD Disclosure
9:25am
8-K
hgx9 wmva94uxe
17 Feb 23
Departure of Directors or Certain Officers
4:31pm
8-K
brc3boyekgtf21r4li8b
8 Feb 23
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
4:09pm
8-K
hir0xxyw zgdl
22 Dec 22
Other Events
7:22pm
8-K
4zsxyr
16 Dec 22
Other Events
5:16pm
8-K
qncy gy7l75fskwtg1
14 Dec 22
Other Events
6:06am
8-K
rxauciv
2 Nov 22
Vanda Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:08pm
8-K
j4cyc6xlel
3 Aug 22
Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results
4:12pm
8-K
wr4c o7ky
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
ncpqyga5 33j
5 May 22
Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results
12:00am
8-K
5te5qm1p3506k8y peau
1 Mar 22
Departure of Directors or Certain Officers
4:06pm
8-K
lmpk0vgp23u49tu9dt
23 Feb 22
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:10pm
8-K
fvta2h
4 Feb 22
Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis
7:07am
8-K
sme4go2c8
14 Jan 22
Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN
4:05pm
8-K
fet1hs
3 Nov 21
Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results
4:08pm
8-K
xczar 59q
8 Oct 21
Departure of Directors or Certain Officers
4:07pm
8-K
weifo oo1ihssa0u0gt
28 Jul 21
Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:08pm
8-K
pgo4p9oxx9lpn4dn
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:01pm